Frankfurts, Blue-Chips

Frankfurt's Blue-Chips Lose Early Gains as Earnings Warnings and Rate Jitters Collide

28.04.2026 - 22:41:58 | boerse-global.de

German blue-chip index closes at 24,018 after rally fades; Qiagen plunges 10.5% on profit warning, Bayer drops 4.6%, while rate hike bets surge on oil spike.

Frankfurt's Blue-Chips Lose Early Gains as Earnings Warnings and Rate Jitters Collide - Foto: über boerse-global.de
Frankfurt's Blue-Chips Lose Early Gains as Earnings Warnings and Rate Jitters Collide - Foto: über boerse-global.de

A promising morning rally evaporated by Tuesday afternoon, leaving the DAX nursing a 0.27 percent decline to close at 24,018 points. The index had touched an intraday high of 24,370 shortly after the opening bell, only to reverse course as a toxic cocktail of corporate disappointments, rising bond yields, and escalating geopolitical tensions soured investor sentiment.

The afternoon sell-off dragged the benchmark to a session low of 23,897, with the final tally representing a net loss of 65 points from the prior close. The day's action leaves the German blue-chip index treading water just above its 50-day moving average of 23,891, while slipping roughly 0.4 percent below the critical 200-day line now sitting at 24,113.

Qiagen's Shock Warning Rattles the Board

The heaviest blow landed on Qiagen, which cratered 10.5 percent after the diagnostics specialist delivered first-quarter numbers that missed expectations and slashed its full-year 2026 guidance. Such a sudden profit warning is rare among DAX constituents and caught the market flat-footed.

Bayer shed 4.6 percent as the US Supreme Court heard oral arguments in the ongoing Roundup litigation. Investors had hoped for clearer signals of relief for the pharmaceutical and agrochemical group, but the session offered no such comfort. Siemens Energy gave back 3.5 percent, a textbook case of profit-taking following the stock's strong run in the prior week.

Should investors sell immediately? Or is it worth buying DAX?

On the upside, Merck climbed 2.3 percent to lead the gainers, while Commerzbank advanced 2.1 percent on rate speculation ahead of the European Central Bank's decision on Thursday.

Airbus Holds Its Ground Despite Quality Concerns

Airbus managed to eke out a 0.53 percent gain after publishing its first-quarter results. The aerospace giant reaffirmed its full-year target of roughly 7.5 billion euros in operating profit, even as it grappled with persistent supply-chain bottlenecks and issues with Pratt & Whitney engines. News of quality defects on fuselage sections weighed on sentiment but failed to derail the stock entirely.

Hugo Boss was less fortunate. The fashion house warned of a weak year ahead, with both revenue and operating profit expected to decline. Management does not foresee a turnaround before 2027, and the stock plunged around 10 percent at the open.

Rate Expectations Flip as Oil Prices Surge

The macro backdrop has darkened considerably. Surging crude prices, driven by an escalation in the Iran conflict, are fanning fears of stagflation across Europe. This has triggered a dramatic repricing in rate expectations: traders now price in as many as two rate hikes by year-end, a stark reversal from the easing bets that dominated earlier in the year.

ECB President Christine Lagarde has offered no forward guidance ahead of Thursday's meeting, though reports suggest some policymakers are already weighing a rate move. The Federal Reserve delivers its own decision on Wednesday, setting up a pivotal 48-hour stretch for global markets.

DAX at a turning point? This analysis reveals what investors need to know now.

Technical Picture Remains Precarious

The DAX's relative strength index stands at 46.6, a neutral reading that offers no directional signal. The 24,000 level held as support during Tuesday's session, but a break below that psychological threshold would open the door to the 23,785 area. On a wider view, the index has shed 2.1 percent since the start of the year, though the 12-month return of 7.8 percent tempers the near-term pain.

With the Fed and ECB decisions looming, along with US consumer confidence data, the coming days will determine whether the DAX can reclaim its footing above the 200-day line or faces a deeper pullback toward the 23,408 support zone.

Ad

DAX Stock: New Analysis - 28 April

Fresh DAX information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated DAX analysis...

So schätzen die Börsenprofis Frankfurts Aktien ein!

<b>So schätzen die Börsenprofis Frankfurts Aktien ein!</b>
Seit 2005 liefert der Börsenbrief trading-notes verlässliche Anlage-Empfehlungen – dreimal pro Woche, direkt ins Postfach. 100% kostenlos. 100% Expertenwissen. Trage einfach deine E-Mail Adresse ein und verpasse ab heute keine Top-Chance mehr. Jetzt abonnieren.
Für. Immer. Kostenlos.
en | DE0008469008 | FRANKFURTS | boerse | 69255032 |